- Joined
- Aug 5, 2007
- Messages
- 977
So, this is a spin-off from the thread about diminishing returns from compounds.
If we believe, or assume, that there is a genuine point of diminishing returns per drug, then would it not make sense to simply add a new compound?
For example, if the point of diminishing returns of Deca is around 400-500mg, why would we desire to push Deca to an extreme dose, rather than add in a second compound?
Please evaluate the pros and cons of a theoretical "hybrid" cycle, using multiple compounds, but only using each compound to the point of diminishing returns for that specific compound.
Example:
Test E: 500mg
Deca: 450mg
EQ: 450mg
Tren E: 400mg
Primo: 400mg
Anadrol: 50mg/day
Dbol: 25mg/day
The total injectable weekly amount is 2200mg. The doses could even be lower, probably.
Would this increase or decrease overall side effects? Vs. using something like 1,500mg test, 600mg Deca
If we believe, or assume, that there is a genuine point of diminishing returns per drug, then would it not make sense to simply add a new compound?
For example, if the point of diminishing returns of Deca is around 400-500mg, why would we desire to push Deca to an extreme dose, rather than add in a second compound?
Please evaluate the pros and cons of a theoretical "hybrid" cycle, using multiple compounds, but only using each compound to the point of diminishing returns for that specific compound.
Example:
Test E: 500mg
Deca: 450mg
EQ: 450mg
Tren E: 400mg
Primo: 400mg
Anadrol: 50mg/day
Dbol: 25mg/day
The total injectable weekly amount is 2200mg. The doses could even be lower, probably.
Would this increase or decrease overall side effects? Vs. using something like 1,500mg test, 600mg Deca
Last edited: